2. Academic Validation
  3. Design, synthesis and biological evaluation of novel c-Met/HDAC dual inhibitors

Design, synthesis and biological evaluation of novel c-Met/HDAC dual inhibitors

  • Bioorg Med Chem Lett. 2020 Dec 1;30(23):127610. doi: 10.1016/j.bmcl.2020.127610.
Yuhong Dong 1,  Hao Hu 1,  Yuwei Sun 1,  Mingze Qin 1,  Ping Gong 1,  Yunlei Hou 2,  Yanfang Zhao 3
Affiliations

Affiliations

  • 1 Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, 103 Wenhua Road, Shenhe District, Shenyang 110016, PR China.
  • 2 Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, 103 Wenhua Road, Shenhe District, Shenyang 110016, PR China. Electronic address: houyunlei901202@163.com.
  • 3 Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, 103 Wenhua Road, Shenhe District, Shenyang 110016, PR China. Electronic address: yanfangzhao@126.com.
PMID: 33045329 DOI: 10.1016/j.bmcl.2020.127610
Abstract

In this work three novel series of c-Met/HDAC bifunctional inhibitors were designed and synthesized by merging pharmacophores of c-Met and HDAC inhibitors. The most potent compound 11j inhibited c-Met kinase and HDAC1 with IC50 values of 21.44 and 45.22 nM, respectively. In addition, 11j showed efficient antiproliferative activities against both MCF-7 and A549 cells with greater potency than the reference drug SAHA and Cabozantinib. This work may lay the foundation for developing novel dual c-Met/HDAC inhibitors as potential Anticancer therapeutics.

Keywords

Antitumor activity; Design; HDAC; Synthesis; c-Met.

Figures
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z